Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04104126 · ClinicalTrials.gov registry record · NA
Blood Flow Restriction Therapy in Achilles Injury
A NA study of Achilles Injuries Tendon, sponsored by NYU Langone Health.
- Recruiting
- Registry status
- NA
- Development phase
- 57
- Enrollment target
- 1
- Study location
NCT04104126 is a NA study of Achilles Injuries Tendon that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 57 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04104126, a NA study of Achilles Injuries Tendon, is actively recruiting participants, sponsored by NYU Langone Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 57 participants
- Enrollment target
- 1
- Study location
Study Summary
Blood flow restriction (BFR) therapy is a brief and partial restriction of venous outflow of an extremity during low load resistance exercises. It is a safe and effective method of improving strength in healthy and active individuals, recovering from orthopedic pathologies and procedures. This prospective, randomized study will look at the implications this form of treatment has on the rehabilitation of Achilles injuries.
Conditions Studied
Interventions
- OTHER Standard of Care Physical Therapy
- OTHER Blood flow restriction
Study Locations (1)
New York
- NYU Langone Health - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2021-10-08 |
| Est. Completion | 2026-06-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04104126
The ClinicalTrials.gov registry entry for NCT04104126 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 57 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Achilles Injuries Tendon appearing as the primary indexed condition, and to 2 interventions - of which Standard of Care Physical Therapy is the first listed.
NCT04104126 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT04104126 about?
NCT04104126 is a clinical study titled "Blood Flow Restriction Therapy in Achilles Injury". Blood flow restriction (BFR) therapy is a brief and partial restriction of venous outflow of an extremity during low load resistance exercises. It is a safe and effective method of improving strength in healthy and active individuals, recovering from orthopedic pathologies and procedures. This prosp...
What is the current status of trial NCT04104126?
This trial is currently recruiting. It is a NA study. The enrollment target is 57 participants. The study started on 2021-10-08. Estimated completion is 2026-06-01.
What conditions does trial NCT04104126 study?
This clinical trial studies the following conditions: Achilles Injuries Tendon.
What interventions are being tested in trial NCT04104126?
The interventions under investigation include: Standard of Care Physical Therapy (OTHER), Blood flow restriction (OTHER).
Who is sponsoring clinical trial NCT04104126?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04104126 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.